Comprehensive genomic profiling of prostate tumours, cell lines and xenografts has revealed that Rb signalling is functionally reduced in 34% of primary tumours and in 74% of castration-resistant tumours, thereby stressing the importance of Rb loss in the emergence of CRPC [31]. This evidence concerns the gene RB1 and prostate neoplasm.